www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

CHINA> News
Race against time to produce flu vaccine
By Ding Qingfen (China Daily)
Updated: 2009-09-10 08:38

Race against time to produce flu vaccine
A technician works on a production line of the Inactivated H1N1 Influenza Vaccine in Sinovac Biotech Ltd, a Chinese vaccine making company, in Beijing. Chinese vaccine maker Sinovac has received approval from Chinese health authorities to mass produce a vaccine for the H1N1 strain of flu. [Agencies]

The 10 Chinese vaccine producers appointed by the government to develop the H1N1 Influenza vaccines are racing against time to finish clinical trials and start mass-producing the drug before the start of the flu season in October.

Beijing Sinovac Biotech, China's leading vaccine manufacturer and one of the 10 producers, received a license for producing vaccines from the State Food and Drug Administration (SFDA) on Sept 3 after the vaccine it developed was approved by a panel of experts.

The vaccine, called Panflu 1, is the first to receive official approval for production worldwide. It means China is likely to be the first nation that could mass-produce a vaccine against the flu.

On July 28, Sinovac Biotech, a joint venture between SinoBioway Group and Sinovac Biotech Ltd, a listed company on the New York Stock Exchange, announced the preliminary clinical trial showed the vaccine was "safe and effective". It was the first in the world to complete preliminary clinical trials.

The preliminary result came from injecting 1,614 volunteers in China.

Currently, there are six Chinese vaccine producers among the 10 that have finished clinical trials and applied for production certificates from the Chinese government. Henan-based Hualan Biological Engineering is expected to be the second company to receive production approval.

Race against time to produce flu vaccine

Industrial sources said most of the 10 vaccine producers would finish clinical trials around October.

Panflu 1 can safely be given to people aged from three to 60 years old in a single 15 microgram dose, according to the evaluation report.

Sinovac Biotech has the capacity to produce 5 million doses of vaccine before Oct 1, and 20 million to 30 million doses per year, said its president, Yin Weidong.

By the end of this year, China will produce H1N1 vaccines for 65 million people, covering 5 percent of the national population.

Suggested groups for vaccination are healthcare workers, who are more likely to be exposed to the virus, pregnant women, people aged above six months with chronic medical conditions such as respiratory and cardiovascular diseases, healthy adults aged 15-49 and children.

Given the population size, Chinese vaccine manufacturers will face a huge challenge meeting the potential needs with limited production capacity, said Keiji Fukuda, assistant director-general of the World Health Organization.

Xinhua reported that the Mexican government would buy 10 million doses of H1N1 flu vaccine from China, bringing its stockpile to 30 million doses, nearly 30 percent of its population.

An online survey by the news portal Sohu.com found that 68.4 percent of the 2,269 respondents said they wanted to be vaccinated.

 

 

主站蜘蛛池模板: 碰碰久久 | videos欧美丰满肥婆 | 亚洲乱码国产一区网址 | 亚洲伊人久久综合影院2021 | 亚洲 [12p]| 日本免费三级网站 | 精品久久久久国产 | 成人网18免费视频 | 色樱桃影院亚洲精品影院 | 国产深夜福利视频网站在线观看 | 一区二区三区影院 | 亚洲综合自拍 | 日韩午夜在线视频 | 国产成人精品一区二区免费视频 | 国产一级第一级毛片 | 欧美在线观看高清一二三区 | 免费一级成人免费观看 | 欧洲乱码伦视频免费 | 成年人毛片视频 | 亚洲一区二区精品视频 | 手机看片日韩国产 | 精品中文字幕在线 | 福利片成人午夜在线 | 亚洲偷自拍另类图片二区 | 国内高清自拍 | 久草免费看 | 波多野结衣视频在线观看地址免费 | 久久www免费人成精品 | 99国产精品久久久久久久日本 | 国产伦码精品一区二区三区 | 2019天天操天天干天天透 | 美女张开腿双腿让男人桶 | 久久久久久久国产免费看 | 久久婷婷影院 | 老司机精品影院一区二区三区 | 亚洲午夜精品 | 日韩精品一区二区三区免费观看 | 成人性色生活片免费网 | 亚洲精品无码不卡在线播放he | 国产精品秦先生手机在线 | 久久中文字幕久久久久 |